FSI's liquidation posture as of March 31, 2026 is marginally positive at the operating asset level but negative at the cash liquidation level, consistent with the MFFAIS estimates (CLV: -$9.7M, LLV: $2.9M, OLV: $13.5M). The balance sheet is dominated by PP&E and accounts receivable, both of which carry meaningful haircut risk in a wind-down. Total assets per segment disclosure were $63.9M at March 31, 2026 versus $61.8M at December 31, 2025, driven primarily by $2.2M of capital expenditures in Q1 2026 concentrated in the BCPA/TPA segment. PP&E net was $17.9M at March 31, 2026 versus $16.1M at December 31, 2025, with gross cost of $31.7M against accumulated depreciation of $13.8M. Manufacturing equipment comprises the largest component at $11.3M net. At a 50-70% recovery haircut, PP&E generates $9.0M-$12.5M of realizable value. A 14,000 sq. ft. former manufacturing facility in Mendota, IL has been reclassified to Property Held for Sale at an estimated net realizable value of $425,000; this is not separately XBRL-tagged in the current filing though it is disclosed in the notes. Total short-term borrowings increased materially QoQ: the ENP Investments revolving line rose from $2.1M to $3.8M, and the NanoChem revolving line rose from $56K to $984K, bringing combined revolver draws to $4.8M at March 31, 2026 versus $2.1M at December 31, 2025. Both facilities are secured by substantially all assets of their respective subsidiaries (excluding IP), creating structural subordination that reduces unsecured creditor and equity recovery. Long-term debt is $4.3M, consisting of four term loans with Stock Yards Bank, all collateralized by real property or manufacturing equipment. Accounts receivable includes a $7.6M balance from a single related-party customer (ENP Investments' NCI counterparty, 'Company A'), up from $6.7M at year-end, representing concentrated counterparty exposure. The equity method investment in a Florida-based LLC stands at $1.5M at March 31, 2026, down from $1.6M due to FSI's proportionate share of Q1 loss of $54K; this entity had net sales of $1.6M in Q1 2026 versus $3.4M in Q1 2025, a significant revenue decline. The 19.9% remaining interest is subject to a structured five-year sale arrangement with a 2025 tranche payment delayed; a $100K penalty was paid by the investee, not the third-party purchaser, raising counterparty risk on future tranches. The filing discloses material weaknesses in ICFR identified at December 31, 2025, with remediation in progress and expected to be complete by Q4 2026. This increases uncertainty around reported asset and liability values. No goodwill or intangible impairment is disclosed in this filing. The filing does not separately XBRL-tag accounts receivable, inventory, cash, goodwill, or intangible asset line items in TAG_CONTEXT, which is empty; all balance-sheet observations are drawn from narrative and embedded XBRL within the filing body.
▼ Community Notes